World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $101.91bn | 28.38 | n/a |
REGNRegeneron Pharmaceuticals | $98.44bn | 24.63 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $41.40bn | 29.47 | n/a |
LONNLonza AG | CH₣36.26bn | 34.92 | 0.8% |
MRNAModerna | $38.83bn | n/a | n/a |
068270Celltrion | KR₩37tn | 45.9 | 0.29% |
ICLRIcon | $23.78bn | 34.05 | n/a |
ARGXargenx SE | €20.05bn | n/a | n/a |
BNTXBioNTech SE | $20.64bn | 20.61 | n/a |
GMABGenmab A/S | DKK131.15bn | 30.38 | n/a |
ALNYAlnylam Pharmaceuticals | $18.19bn | n/a | n/a |
NBIXNeurocrine Biosciences | $13.28bn | 37.25 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
CRLCharles River Laboratories International | $11.68bn | 28.64 | n/a |
MEDPMedpace Holdings | $11.53bn | 41.91 | n/a |
UTHRUnited Therapeutics | $11.20bn | 11.97 | n/a |
EXASExact Sciences | $11.07bn | n/a | n/a |
SRPTSarepta Therapeutics | $10.85bn | n/a | n/a |
TECHBIO-TECHNE | $9.76bn | 43.15 | 0.52% |